Related Experiment Video
Updated: Aug 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A
Janice M Kerr1, David F Gordon, Whitney W Woodmansee
1University of Colorado Health Sciences Center, Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, MS8106, P.O. Box 6511 Denver, CO 80262, USA. janice.kerr@uchsc.edu
Abstract:
The molecular mechanism underlying thyroid hormone inhibition of thyrotrope cell growth is poorly understood. A comprehensive screen for T3-regulated genes involved in thyrotrope cell regulation was performed by Affymetrix MGU74A Genechip microarray analyses, which compared total RNA from hypothyroid versus 24 h T3-treated TtT-97 tumors. Of the 13,000 genes screened, a number of novel, T3-responsive candidate genes were identified. Within the Wnt family of growth factors, only Wnt-10A transcripts were abundantly expressed in hypothyroid TtT-97 tumors, and were down-regulated with T3 by 6 h of treatment. In addition, nuclear beta-catenin, which is a downstream mediator of canonical Wnt signaling, was decreased at the protein and functional levels. TtT-97 growth suppression was associated with decreased cyclin A transcript levels. We conclude that treatment of thyrotropic TtT-97 tumors with T3 resulted in the decreased expression of Wnt-10A, and that thyroid hormone may inhibit growth via cyclin A regulation.
Insights
Thyroid hormone (T3) inhibits thyrotrope cell growth by down-regulating Wnt-10A expression and reducing beta-catenin signaling. This pathway may involve cyclin A regulation, impacting tumor growth.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- The precise molecular mechanisms by which thyroid hormone (T3) regulates thyrotrope cell proliferation remain largely unknown.
- Understanding these mechanisms is crucial for comprehending thyroid hormone's role in pituitary function and potential therapeutic interventions.
Purpose of the Study:
- To identify novel T3-regulated genes involved in the growth control of thyrotrope tumor cells.
- To elucidate the molecular pathways through which T3 inhibits thyrotrope cell proliferation.
Main Methods:
- Utilized Affymetrix MGU74A Genechip microarray analysis to compare gene expression profiles between hypothyroid and T3-treated TtT-97 tumors.
- Assessed protein and functional levels of beta-catenin and transcript levels of cyclin A.
Main Results:
- Identified Wnt-10A as a T3-down-regulated gene abundantly expressed in hypothyroid TtT-97 tumors.
- Observed decreased nuclear beta-catenin protein and function following T3 treatment.
- Found that TtT-97 tumor growth suppression correlated with reduced cyclin A transcript levels.
Conclusions:
- Thyroid hormone (T3) treatment leads to decreased Wnt-10A expression in thyrotropic tumors.
- Thyroid hormone may inhibit thyrotrope cell growth through the regulation of Wnt-10A and subsequent modulation of cyclin A levels.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...